In vitro assessment of infant pulmonary function equipment.

PubWeight™: 1.41‹?› | Rank: Top 5%

🔗 View Article (PMID 7617406)

Published in Pediatr Pulmonol on April 01, 1995

Authors

E A Jackson1, A L Coates, M Gappa, J Stocks

Author Affiliations

1: Portex Department of Anaesthesia, Intensive Care and Respiratory Medicine, Institute of Child Health, London, U.K.

Articles by these authors

Guidelines for methacholine and exercise challenge testing-1999. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, July 1999. Am J Respir Crit Care Med (2000) 9.44

Definition, assessment and treatment of wheezing disorders in preschool children: an evidence-based approach. Eur Respir J (2008) 3.36

Using the lower limit of normal for the FEV1/FVC ratio reduces the misclassification of airway obstruction. Thorax (2008) 3.30

A new apparatus for the accurate measurement of airway resistance in infancy. J Appl Physiol Respir Environ Exerc Physiol (1977) 3.09

The autoxidation of human red cell lipids induced by hydrogen peroxide. Br J Haematol (1971) 2.77

Respiratory function among preterm infants whose mothers smoked during pregnancy. Am J Respir Crit Care Med (1998) 2.66

Caeruloplasmin: physiological and pathological perspectives. Crit Rev Clin Lab Sci (1981) 2.32

The need to change the method for defining mild airway obstruction. Eur Respir J (2011) 2.30

DNA polymorphism adjacent to human apoprotein A-1 gene: relation to hypertriglyceridaemia. Lancet (1983) 2.28

Measurement of lung volumes by plethysmography. Eur Respir J (1997) 2.08

A multicenter, randomized, double-blind, placebo-controlled trial of high-dose intravenous immunoglobulin for oral corticosteroid-dependent asthma. Clin Immunol (1999) 2.04

A genome-wide search for linkage to asthma. German Asthma Genetics Group. Genomics (1999) 2.00

Pvu-II RFLP at the human lipoprotein lipase (LPL) gene locus. Nucleic Acids Res (1988) 1.99

Influence of secular trends and sample size on reference equations for lung function tests. Eur Respir J (2010) 1.88

Multiple breath inert gas washout as a measure of ventilation distribution in children with cystic fibrosis. Thorax (2004) 1.86

The long-term pulmonary sequelae of prematurity: the role of familial airway hyperreactivity and the respiratory distress syndrome. N Engl J Med (1985) 1.76

Deoxyribonucleic acid polymorphism in the apolipoprotein A-1-C-III gene cluster. Association with hypertriglyceridemia. J Clin Invest (1985) 1.73

Airway function in infants newly diagnosed with cystic fibrosis. Lancet (2001) 1.72

Sex differences in habitual physical activity and lung function decline in children with cystic fibrosis. J Pediatr (2005) 1.64

The inhibition of lipid autoxidation by human serum and its relation to serum proteins and alpha-tocopherol. Clin Sci Mol Med (1974) 1.61

The susceptibility to autoxidation of human red cell lipids in health and disease. Br J Haematol (1972) 1.60

Reference values for lung function: past, present and future. Eur Respir J (2010) 1.58

Specifications for equipment used for infant pulmonary function testing. ERS/ATS Task Force on Standards for Infant Respiratory Function Testing. European Respiratory Society/ American Thoracic Society. Eur Respir J (2000) 1.57

Impaired airway function and wheezing in infancy: the influence of maternal smoking and a genetic predisposition to asthma. Am J Respir Crit Care Med (1999) 1.55

Clinical application of regional lung function studies in infants and small children using 13N. Arch Dis Child (1975) 1.47

DNA polymorphisms at the lipoprotein lipase gene: associations in normal and hypertriglyceridaemic subjects. Atherosclerosis (1989) 1.47

Noninvasive determination of cardiac output in patients with severe airflow limitation. Am J Respir Crit Care Med (1996) 1.40

Nucleotide sequence of PvuII polymorphic site at the human lipoprotein lipase gene locus. Nucleic Acids Res (1989) 1.38

[Omalizumab therapy in adolescents with severe allergic asthma - results of a post-marketing surveillance]. Pneumologie (2013) 1.38

Tidal forced expirations. ERS/ATS Task Force on Standards for Infant Respiratory Function Testing. European Respiratory Society/American Thoracic Society. Eur Respir J (2000) 1.33

Age- and size-related reference ranges: a case study of spirometry through childhood and adulthood. Stat Med (2009) 1.30

Nasal resistance during infancy. Respir Physiol (1978) 1.30

Long-term pulmonary sequelae of premature birth with and without idiopathic respiratory distress syndrome. J Pediatr (1977) 1.30

Effect of nasogastric tubes on nasal resistance during infancy. Arch Dis Child (1980) 1.29

Compilation of reference values for lung function measurements in children. Eur Respir J Suppl (1989) 1.26

Tidal breath analysis for infant pulmonary function testing. ERS/ATS Task Force on Standards for Infant Respiratory Function Testing. European Respiratory Society/American Thoracic Society. Eur Respir J (2000) 1.24

Nature and severity of lung function abnormalities in extremely pre-term children at 11 years of age. Eur Respir J (2010) 1.24

Assay using brain homogenate for measuring the antioxidant activity of biological fluids. Clin Sci Mol Med (1974) 1.23

Long-term pulmonary sequelae of severe bronchopulmonary dysplasia. J Pediatr (1998) 1.21

Long-term tobramycin aerosol therapy in cystic fibrosis. Pediatr Pulmonol (1989) 1.20

The EPICure study: comparison of pediatric spirometry in community and laboratory settings. Pediatr Pulmonol (2008) 1.20

Lung development and early origins of childhood respiratory illness. Br Med Bull (1997) 1.20

Spirometry in the asthmatic child: is FEF25-75 a more sensitive test than FEV1/FVC? Pediatr Pulmonol (1993) 1.18

Total respiratory compliance and functional residual capacity in young children. Pediatr Pulmonol (1987) 1.17

The influence of endotracheal tube leak on the assessment of respiratory function in ventilated children. Intensive Care Med (2001) 1.16

The functional growth and development of the lung during the first year of life. Early Hum Dev (1977) 1.16

Urinary copper excretion in rheumatoid arthritis. Ann Rheum Dis (1975) 1.15

Progressive platelet activation with storage: evidence for shortened survival of activated platelets after transfusion. Transfusion (1991) 1.15

Multiple factors limit exercise capacity in cystic fibrosis. Pediatr Pulmonol (1986) 1.14

Maternal anthropometry and idiopathic preterm labor. Obstet Gynecol (1995) 1.13

Specific airway conductance in relation to postconceptional age during infancy. J Appl Physiol Respir Environ Exerc Physiol (1977) 1.11

Passive respiratory mechanics: the occlusion techniques. Eur Respir J (2001) 1.11

Improved esophageal balloon technique for use in infants. J Appl Physiol Respir Environ Exerc Physiol (1980) 1.11

Low birth weight for gestation and airway function in infancy: exploring the fetal origins hypothesis. Thorax (2004) 1.10

Immediate and long-term effects of chest physiotherapy in patients with cystic fibrosis. J Pediatr (1983) 1.09

The association between birthweight, sex, and airway function in infants of nonsmoking mothers. Am J Respir Crit Care Med (2001) 1.08

Association of prematurity, lung disease and body size with lung volume and ventilation inhomogeneity in unsedated neonates: a multicentre study. Thorax (2008) 1.07

The role of artificial ventilation, oxygen, and CPAP in the pathogenesis of lung damage in neonates: assessment by serial measurements of lung function. Pediatrics (1976) 1.06

The numerical analysis of pressure-flow curves in infancy. Pediatr Pulmonol (1985) 1.06

An abnormal triglyceride-rich lipoprotein containing excess sialylated apolipoprotein C-III. J Clin Invest (1982) 1.04

Measurement of lung volumes in humans: review and recommendations from an ATS/ERS workshop. Eur Respir J (1997) 1.04

Human airway smooth muscle cells secrete vascular endothelial growth factor: up-regulation by bradykinin via a protein kinase C and prostanoid-dependent mechanism. FASEB J (2001) 1.04

Genetic polymorphisms of apolipoprotein C-III and insulin in survivors of myocardial infarction. Lancet (1985) 1.04

Severe bronchopulmonary dysplasia increases risk for later neurological and motor sequelae in preterm survivors. Dev Med Child Neurol (2000) 1.03

Bronchial hypersecretion in preterm neonates. Arch Dis Child (1982) 1.03

DNA polymorphisms in the apolipoprotein C-III and insulin genes and atherosclerosis. Atherosclerosis (1985) 1.03

Changes in the FEV₁/FVC ratio during childhood and adolescence: an intercontinental study. Eur Respir J (2010) 1.03

Cardiac output and oxygen delivery during exercise in sickle cell anemia. Am Rev Respir Dis (1991) 1.02

Haplotypes identified by DNA polymorphisms at the apolipoprotein A-1 and C-III loci and hypertriglyceridaemia. A study in a Japanese population. Hum Genet (1986) 1.01

Imaging of the small bowel by capsule endoscopy in Whipple's disease. Endoscopy (2009) 1.00

Problems in measurement of thoracic gas volume in infancy. J Appl Physiol Respir Environ Exerc Physiol (1982) 1.00

Pulse oximetry in sickle cell disease. Arch Dis Child (1993) 1.00

Assessment of the catheter tip pressure transducer for use in infant lung function tests. Med Biol Eng Comput (1982) 0.99

Ventilation and gas exchange during exercise in sickle cell anemia. Am Rev Respir Dis (1991) 0.99

Oxygen therapy and long-term pulmonary outcome of respiratory distress syndrome in newborns. Am J Dis Child (1982) 0.99

Pulmonary function abnormalities in childhood sickle cell disease. J Pediatr (1993) 0.99

Lipoprotein and hepatic lipase gene variants in coronary atherosclerosis. Atherosclerosis (1990) 0.99

Neonatal Ventilation With Inhaled Nitric Oxide Versus Ventilatory Support Without Inhaled Nitric Oxide for Preterm Infants With Severe Respiratory Failure: the INNOVO multicentre randomised controlled trial (ISRCTN 17821339). Pediatrics (2005) 0.99

High-fibre and low-fat diets in diabetes mellitus. Br J Nutr (1981) 0.98

The bias flow nitrogen washout technique for measuring the functional residual capacity in infants. ERS/ATS Task Force on Standards for Infant Respiratory Function Testing. Eur Respir J (2001) 0.98

Predictive values of component-specific IgE for the outcome of peanut and hazelnut food challenges in children. Allergy (2014) 0.97

DNA polymorphic patterns and haplotype arrangements of the apo A-1, apo C-III, apo A-IV gene cluster in different ethnic groups. Hum Genet (1987) 0.97

Determinants of lung volume in spontaneously breathing preterm infants. Am J Respir Crit Care Med (1997) 0.96

Airway function at one year: association with premorbid airway function, wheezing, and maternal smoking. Thorax (2001) 0.96

Increased susceptibility of red-blood-cell lipids to autooxidation in haemolytic states. Lancet (1971) 0.96

Comparison of nitrogen washout and plethysmographic measurements of lung volume in healthy infants. Am Rev Respir Dis (1993) 0.95

Airway resistance in infants after various treatments for hyaline membrane disease: special emphasis on prolonged high levels of inspired oxygen. Pediatrics (1978) 0.95

Lung function testing in infants with cystic fibrosis: lessons from the past and future directions. Pediatr Pulmonol (2001) 0.94

Threshold for classification as a skin sensitizer in the local lymph node assay: a statistical evaluation. Food Chem Toxicol (1999) 0.94

Primary lung abscess in childhood: the long-term outcome of conservative management. Am J Dis Child (1982) 0.94

The relationship between tPTEF:tE and specific airway conductance in infancy. Pediatr Pulmonol (1994) 0.93

Generalized pulmonary hyperinflation and Fallot's tetralogy in a neonate investigated by pulmonary physiological and radioisotopic methods. Thorax (1975) 0.93

The effects of inspiratory muscle training in patients with cystic fibrosis. Am Rev Respir Dis (1982) 0.93

The role of nutritional status, airway obstruction, hypoxia, and abnormalities in serum lipid composition in limiting exercise tolerance in children with cystic fibrosis. Acta Paediatr Scand (1980) 0.93

High density lipoprotein subfractions and coronary risk factors in normal men. Arteriosclerosis (1987) 0.92

Functional residual capacity measurements in healthy infants: ultrasonic flow meter versus a mass spectrometer. Eur Respir J (2004) 0.92

Nocturnal home oxygen in the treatment of hypoxemic cystic fibrosis patients. J Pediatr (1989) 0.92